Divi's Laboratories Limited

Government of Singapore reduced its stake in Divi's Laboratories from 3.64% to 2.84%, selling 21,14,004 shares.

A leading manufacturer and exporter of active pharmaceutical ingredients, intermediates, and nutraceutical ingredients serving global pharmaceutical and healthcare markets. Incorporated in 1990, the company operates across multiple therapeutic segments with vertically integrated manufacturing infrastructure. It distinguishes itself through expertise in complex chemistry, stringent quality standards, and a diversified product portfolio catering to customers worldwide.

Singapore sovereign investor (GIC), managing the Government of Singapore's foreign reserves. One of the world's largest SWFs with significant Indian equity holdings.